Published: 8 March 2024
Author(s): Hiroshi Ito
Issue: May 2024
Section: Letter to the Editor

Jahn K et al. conducted a prospective single-center observational study and found that treatment management changed in approximately half of the patients with immunocompromised lower respiratory tract infections undergoing bronchoalveolar lavage (BAL) examination [1]. Differential diagnosis of pulmonary lesions in immunocompromised patients is more diverse compared to immunocompetent patients [2], and while there are frequent situations where BAL examination is preferable, there is also a dilemma in clinical practice where BAL examination cannot actually be performed due to its invasiveness.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.